MedTrace Logo

Increasing Influenza and Tdap Vaccination of Pregnant Women

NCT04444518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12760

Last updated 2025-01-10

Study results available
· View outcomes & findings →

Summary

Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.

Conditions

  • Immunization; Infection
  • Pregnancy Related

Interventions

BEHAVIORAL

VAX-MOM Intervention

The multi-component VAX-MOM intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.

BEHAVIORAL

Standard of Care

Standard vaccine education and processes provided to patients by obstetric practices.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04444518 on ClinicalTrials.gov